Skip to Main Content

Paper Details

IGF2BP3 as a Prognostic Biomarker in Well-Differentiated/Dedifferentiated Liposarcoma.
Cancers (Basel)
0
2023
Author NameAffiliation
Sarah M DryJonsson Comprehensive Cancer Center, University of California los angeles
Sarah M DryUniversity of California, Los Angeles David Geffen School of Medicine
Fritz C EilberUniversity of California, Los Angeles David Geffen School of Medicine
Fritz C EilberJonsson Comprehensive Cancer Center, University of California los angeles
Anusha KalbasiStanford Cancer Institute, Stanford School of Medicine
  • 1 - 5

Datasets